
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Breast malignant, males, children
In situ carcinoma
Basal-like DCIS
Reviewer: Monika Roychowdhury, M.D. (see Reviewers
page)
Revised: 4 February 2012, last major update February 2012
Copyright: (c) 2001-2012, PathologyOutlines.com, Inc.
General
=========================================================================
● Classified based on immunohistochemistry or gene expression profiling
(Breast Cancer Res 2006;8:R61),
not morphology
● 8% of DCIS
● Of academic interest only, not currently used clinically
Epidemiology
=========================================================================
● Associated with high grade nuclei, p53 overexpression, increased Ki-67 index
(Hum Pathol 2007;38:197),
but only a small percentage of high grade DCIS has basal-like phenotype
(Mod Pathol 2006;19:617)
● Commonly found with invasive basal-like carcinomas
(Mod Pathol 2006;19:1506)
● DCIS lesions in BRCA1 mutation carriers are mostly basal-like
(J Clin Pathol 2009;62:926)
Micro description
=========================================================================
● Solid, flat or micropapillary
● High nuclear grade, comedonecrosis, intense lymphocytic infiltrate
Micro images
=========================================================================
![]()
H&E and stains
![]()
H&E and variable CK5/6 staining
Positive stains
=========================================================================
● CK5/6, CK14 or CK17
● Usually EGFR or c-kit/CD117
● Also vimentin, alphaB-crystallin
(Ann Diagn Pathol 2008;12:33),
P-cadherin (Virchows Arch 2007;450:73)
Negative stains
=========================================================================
● By definition is ER-, PR- and HER2-
End of Breast malignant, males, children > In situ carcinoma > Basal-like DCIS
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).